VIRTUAL: Accelerating Gene Editing Workflows Towards the Clinic

Time: 12:00 pm
day: Day One


  • Approaching the FDA with confidence about On / Off target analytics and safety determinations
  • Aligning nuclease license and guide production from research to clinic from the beginning
  • Automation brings editing and screening depth sufficient for creating multi-edited MCB